There is insufficient evidence to support a strong recommendation about the diagnostic accuracy of imaging to detect pseudoaneurysms.
Level IIIn the absence of direct scientific evidence, EXPERT CONSENSUS concluded that:
Timing
CTA vs. DSA
Benefits, Harms, Accuracy
No evidence or expert opinion supported distinct recommendations based on patient gender, age, wounding mechanism, or military vs. civilian context.
pTBI frequently results in cerebrovascular injuries, leading to conditions such as traumatic intracranial aneurysms (TICA), arteriovenous fistula (AVF), and cerebral vasospasm, which if untreated, can significantly increase morbidity and mortality risks.
CTA offers a quick and accessible means for imaging the intracranial vasculature, yet DSA remains the more sensitive and specific gold standard, despite its lower availability and more invasive nature. The management of cerebrovascular injuries is complicated by the potential for delayed TICAs, which can develop subsequent to initial imaging.
The current guidelines effort endeavored to address the evidence related to optimal diagnosis and treatment of vascular injury from penetrating trauma. This section focuses on the evidence related to diagnosis, addressing three key areas: 1) the accuracy of DSA and CTA in pTBI, 2) the benefits and harms of DSA, and 3) the optimal timing of initial and delayed vascular imaging.
The prior penetrating head injury guidelines addressed the "Neuroimaging in the Management of Penetrating Brain Injury" and the "Vascular Complications of Penetrating Brain Injury."
Three studies (N=174) found the sensitivity of CTA, with DSA as the reference standard, to be 36%, 50%, and 73% for cerebral artery injury in a civilian setting in the United States with most patients victims of GSWs (86%, 86%, and 89%, Table 1).
Diagnostic accuracy of CTA varied across studies (especially sensitivity), across readers within one study, and whether or not metallic artifacts were present. These studies provide moderate strength evidence that DSA detects a greater number of vascular injuries than CTA in the setting of GSW to the head. These studies also provide very low strength of evidence that diagnostic accuracy of CTA to detect pseudoaneurysms is moderate to high when using DSA as the reference standard. However, due to other factors such as severity of injury and risk of neurological complications, the evidence is insufficient to determine when DSA should best occur or when DSA may be preferred over CTA.
Ten studies meeting inclusion criteria for formal use as evidence reported results of cerebral angiography in patients with pTBI, with a total of more than 1320 angiograms conducted (number not reported in one study) (Table).
Benefits. The primary benefit from screening for traumatic intracranial arterial aneurysms (TICAs) and cerebral vasospasm (VSP) is the potential for lifesaving/morbidity-reducing intervention(s) that would not have occurred without screening. The rate at which TICAs were identified varied across seven studies,
Five studies reported Glasgow Outcome Scale (GOS) scores for patients with TICAs, on a scale from 1 to 5 with higher scores representing better outcomes. Mean GOS ranged from 3.1 to 4.4 (severe to moderate disability) across three studies; in the fourth, 66% had scores of 4 or 5 (moderate to low disability). In the fifth most recent study, mean GOS ranged from 1-5 with a mean of 4.
Harms. The primary harms of screening for TICA and VSP are any increase in morbidity/mortality due to the screening process (cerebral angiography), as well as any increase in morbidity/mortality due to any intervention provided because of a positive screen. The data on harms of screening and harms of treatment due to screening are sparse. One study stated there was "no procedure-related morbidity or mortality" and no groin complications.
Diagnostic Accuracy. Two studies reported information relevant to the diagnostic accuracy of cerebral angiogram. Because cerebral angiogram is most often considered the reference standard for detection of intracerebral vascular lesions, we did not identify studies reporting true diagnostic accuracy outcomes for angiography, and we did not assess strength of evidence for these outcomes. One study described a U.S. civilian population, with 45 patients who received both cerebral angiography and CTA.
A study from South Africa found one patient with a TICA among 15 undergoing cerebral angiography.
One study from Turkey did not meet inclusion criteria (62% with intracranial injury [and some of those injuries may not have been penetrating] which is less than the inclusion cutoff of 85% with penetrating injury when study finding are not reported by penetrating versus nonpenetrating injury), but reported 115 patients with missile head injuries who received conventional angiography; 82 patients had magnetic resonance angiography (MRA) as well as angiogram.
Another study that did not meet inclusion criteria (75% with penetrating brain injury) retrospectively reviewed the charts of patients from the Iraq war and reported that 47% of 57 patients were found to have VSP (mean duration 14.3 days) identified by CTA.
One study (N=181) in South Africa in victims of stab wounds to the head reported outcomes in patients who underwent angiography within 7 days of injury or after 7 days and reported no statistically significant difference in the identification of vascular injury (p=0.183) between early and late angiography, although a higher proportion of patients were found with vascular injury in the group (N=51) who underwent angiography after 7 days (41% vs. 31%).
Nine case series were included which addressed benefits and harms of screening for delayed vascular complications and included both military and civilian populations. Most injuries were blast-related or GSWs. The three largest case series included 26 patients with pTBI and 60% blast-related intracranial vascular injury in Iraq,
In one case series (N=26), all patients received DSA and repeat angiography.
A second case series (N=13 patients with GSWs and follow-up CTA) reported 44.4% vascular injury on initial CTA.
A third case series (N=24 with repeat imaging; details provided for 9 TICA patients).
These studies plus the smaller case series in the table provide low strength evidence that repeat vascular imaging may yield different findings from initial imaging (e.g., new or unrecognized vascular injury, worsening injury, improved injury [with or without treatment], resolution of vascular injury).
The importance of timely and accurate diagnosis of traumatic pseudoaneurysms following penetrating traumatic brain injury (pTBI) is significant, given their high risk of growth and rupture leading to high mortality. The discussion around the best screening modality for detecting cerebrovascular injuries post-pTBI highlights the complexity and urgency of this medical challenge. Traumatic pseudoaneurysms represent the most common histologic type observed after pTBI, necessitating urgent management to prevent life-threatening consequences. The treatment of pTBI induced traumatic cerebrovascular injury will be addressed in Sections VII-6, VII-7, and the Management Algorithm. This section addressed issues related to imaging of cerebrovascular imaging specifically.
Historically, the guidelines for managing penetrating brain injuries have recommended vascular injury screening using angiography, particularly in cases where the trajectory of the wound suggests an increased risk of vascular injury.
The scientific foundation, one prospective study and two retrospective study led to a level II recommendation in support of DSA for high-risk patients.
While both CTA and DSA offer valuable insights into cerebrovascular injuries post-pTBI, the decision on which modality to employ should be guided by the specific clinical context, including the availability of technology, expertise, and the patient's condition. Given the high stakes of missing or delaying the diagnosis of a traumatic pseudoaneurysm, a conservative approach involving the use of the most accurate and reliable diagnostic tools available is warranted. Screening for traumatic pseudoaneurysms should be conducted as soon as feasible, with a preference for DSA where practical, given its role as a reference gold standard. However, in settings where DSA is not readily available or feasible, CTA serves as a critical tool, with the understanding that follow-up or confirmatory testing may be necessary. The ultimate goal is to ensure the prompt and accurate detection of these potentially life-threatening injuries to facilitate timely and appropriate management.
The discussion of the diagnostic accuracy of DSA and CTA above underlines the importance of accurate screening and detection. It can be argued that the most significant harm of DSA is in not performing one. Missing a traumatic aneurysm that subsequently ruptures is a worst case scenario, and in skilled hands entirely preventable. In context, the prior penetrating head injury guidelines provided recommendations at the lowest level for that work, or Option (Level III/IV), which admixed low level evidence with expert opinion. The currently available evidence (Level III) related to this question supports screening for traumatic intracranial aneurysms with DSA to improve survival. Coupled with the Level II recommendation supporting DSA over CTA in high-risk patients with pTBI, this subject represents one of the most meaningful areas of this guidelines.
Because DSA is considered the reference standard for cerebrovascular imaging, it is possible to assess the diagnostic accuracy of CTA in comparison (see above). There currently is no reference standard for DSA, and therefore no evidence backing its gold-standard designation.
The question of when to perform vascular imaging following a penetrating brain injury is one that is incompletely addressed by current high quality, includable evidence. That said, there may be none more important. The incidence and natural history of traumatic aneurysms from pTBI has been studied and is, at least in part, known.
A key impetus for updating the pTBI guidelines was diverse views in the field related to screening for and treating TICAs. Here we provide evidence-based and consensus recommendations aimed at identifying and promoting best care practices. In response to gaps in direct scientific evidence that include the optimal timing for initial and repeat vascular imaging and specific clinical indicators for penetrating traumatic brain injury (pTBI), an expert consensus through Delphi voting (Level C) offers guidance on the utilization of Digital Subtraction Angiography (DSA) and Computed Tomography Angiogram (CTA) in specific scenarios. The consensus underscores the importance of precise diagnostic approaches in managing pTBI, reflecting unanimous agreement (100% consensus) on several key recommendations including the high risk pTBI features that should prompt DSA. These include injuries with a wound trajectory that intersects or lies adjacent to major cerebral vasculature, violations involving multiple dural compartments, facio-orbito-pterional entry wounds, or the presence of an intracerebral hematoma. In situations where CTA is unable to conclusively rule out vascular injury (nearly all cases) - often due to interference from streak artifacts caused by retained metallic fragments or bone fragments/foreign bodies near intracerebral vasculature - DSA is recommended to ensure accurate diagnosis. For patients whose CTA results have confirmed vascular injuries, obtaining a DSA is advised to further investigate and plan appropriate interventions. Our panelists feel that DSA has numerous important advantages over CTA including improve sensitivity and specificity along with the ability to treat identified pathology. We acknowledge that it does have procedural risks which CTA does not.
Upon the initial CT scan for patients with pTBI, a CTA should be conducted to screen for any vascular injuries, providing a comprehensive understanding of the extent of damage from the outset. It is suggested that repeat early vascular imaging be performed between 7 to 21 days following the injury or before the patient's discharge from the hospital. This recommendation aims to identify any delayed vascular complications - in particular TICA - that are known to arise in delayed fashion.
An additional recommendation concerning vasospasm associated with pTBI was also made. Direct evidence meeting inclusion criteria concerning vasospasm was lacking. Referencing the section on treatment (Section VII-6, Treatment of Traumatic Pseudoaneurysms), the clinical significance of pTBI induced vasospasm remains somewhat uncertain.
These expert consensus recommendations highlight a strategic approach to diagnosing and managing vascular injuries in pTBI, emphasizing the critical role of DSA and CTA in ensuring timely and effective care.
It is imperative to conduct further research comparing Computed Tomography Angiogram (CTA) and Digital Subtraction Angiography (DSA) in patients with penetrating traumatic brain injury (pTBI) to discern their relative efficacies, sensitivities, and specificities. As advancements in CTA technology continue to enhance its diagnostic accuracy, it's conceivable that DSA's role might diminish due to its invasive nature and associated higher morbidity risks. Moreover, in-depth investigations into the progression of vascular lesions post-pTBI are crucial for establishing the most opportune time for diagnostic imaging. These studies will not only refine our understanding of lesion development but also aid in refining the most effective timing for imaging, thereby optimizing patient outcomes. Other studies should focus on the development and validation of advanced imaging modalities or techniques that surpass the current limitations of CTA and DSA, particularly in sensitivity, specificity, and the ability to minimize artifacts from metallic fragments. Research into machine learning algorithms that can improve image interpretation and reduce variability among readers could also be transformative. There is also a significant gap in understanding the optimal timing for initial and repeat imaging to detect vascular injuries post-pTBI. Longitudinal studies that track the progression of vascular injuries over time could provide invaluable insights into when these injuries manifest and evolve, potentially leading to more timely interventions. The development of biomarkers for vascular injury that could predict the development of TICA or AVF after pTBI would be powerful. Such biomarkers could facilitate earlier identification of patients at high risk of developing these vascular complications, guiding more targeted imaging and intervention strategies.